Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRTA · against 1,335 other Healthcare companies
Ranked #742 of 1,336 · scores higher than 44% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 40–49, including SRTA · Click a bar to see the companies
A mix: stronger return on assets, but weaker operating margin and return on invested capital than most Healthcare peers.
| Metric | SRTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -6.1% | 4.7% | 28% | 33% | |
| Operating marginHigher is better · 1,251 reported | -8.0% | 7.1% | 26% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 12.1% | 1.7% | 93% | 33% | |
| Return on equityHigher is better · 1,252 reported | -9.2% | 3.2% | 33% | Context only | |
| Gross marginHigher is better · 1,394 reported | 21.3% | 45.9% | 25% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 742 | 1.2B SGD (≈$945M) | 44 | 35 | |
| 742 | 116.9B USD | 44 | 47 | |
| 742 | 965M EUR (≈$1.1B) | 44 | 37 | |
| 742 | 759M USD | 44 | 54 | |
| 742 | 393M USD | 44 | 61 | |
| 742 | 1.3B USD | 44 | 58 | |
| 742 | 3.0B CHF (≈$3.5B) | 44 | 33 | |
| 756 | 2.5B CNY (≈$345M) | 43 | 39 | |
| 756 | 3.0B CNY (≈$427M) | 43 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score